Traders Recap: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), NetEase Inc (ADR) (NASDAQ:NTES)

On Monday, Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), added 5.88% and closed at $7.20 in the last trading session. The last trading range of the stock ranges between $6.71 and $7.30. ZIOPHARM Oncology, Inc. (ZIOP) recently declared that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference on Thursday, November 17, 2016 at 4:40 p.m. GMT.

As formerly declared, ZIOPHARM will host a conference call and webcast slide presentation Thursday, November 17, 2016, at 8:00 am ET to discuss information featured at the Society for Neuro-Oncology (SNO) Annual Meeting, counting updated data from the Company’s Phase 1 study of Ad-RTS-hIL-12 + veledimex in high-grade glioma. The call can be accessed by dialing (844) 309-0618 (U.S. and Canada) or (661) 378-9465 (international). The passcode for the conference call is 11110235. To access the slides and live audio webcast, or the subsequent archived recording, visit the “Shareholders & Media” section of the ZIOPHARM website.

NetEase Inc (ADR) (NASDAQ:NTES), dropped -7.10% and closed at $217.91 in the last trading session. The last trading range of the stock ranges between $216.39 and $235.61. The company’s Market capitalization is $29.65 Billion with the total Outstanding Shares of 3.29 billion. NetEase, Inc. (NTES) (“NetEase” or the “Company”), one of China’s leading internet and online game services providers, recently declared that its Board of Directors has approved a new share repurchase program of up to US$1.0 billion of the Company’s outstanding American Depositary Shares (ADSs) for a period not to exceed 12 months.

Under the terms of the approved program, NetEase may repurchase its issued and outstanding ADSs in open-market transactions on the NASDAQ Global Select Market. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission (SEC) Rule 10b-18 requirements. It is also expected that such repurchases will be effected following a plan in conformity with SEC Rule 10b5-1. The extent to which NetEase repurchases its ADSs will depend upon various factors, counting market conditions, regulatory requirements and other corporate considerations, as determined by NetEase’s administration team. The repurchase program may be suspended or suspended at any time. NetEase plans to fund repurchases made under this program from available working capital.

Leave a Reply

Your email address will not be published. Required fields are marked *